Mucolytic bacteria: prevalence in various pathological diseases

Area of Science:

• Microbiology
• Biochemistry
• Immunology

Background:

• Mucins are vital, highly glycosylated proteins forming protective mucus layers in humans and animals.
• Mucus layers have distinct bilayers: an outer, microbe-harboring layer and an inner, sterile layer.
• Pathogen adhesion to mucins and subsequent disruption of mucus integrity can lead to disease.

Purpose of the Study:

• To review the role of bacterial species in mucin degradation and its impact on host health.
• To explore how bacterial interactions with mucins contribute to various organ system diseases.
• To identify potential therapeutic targets by understanding mucin-degrading pathogens.

Main Methods:

• Systematic review of scientific literature.
• Analysis of bacterial mechanisms involved in mucin degradation.
• Examination of the link between mucin-pathogen interactions and disease pathogenesis.

Main Results:

• Certain bacteria degrade mucins, compromising the mucus barrier's protective functions.
• Alterations in mucus secretion, composition, and gene expression are linked to disease.
• Dysbiotic microbiomes and defective mucus barriers contribute to inflammatory and infectious diseases.

Conclusions:

• Bacterial mucin degradation is a significant factor in the etiology of diseases like cystic fibrosis and ulcerative colitis.
• Targeting mucin-degrading bacteria offers a promising avenue for novel therapeutic strategies.
• Further research into mucin-pathogen interactions can enhance our understanding and treatment of complex disorders.